Heron Therapeutics (HRTX) Q2 2023 Earnings

14AugConfirmed
Nov 22
Q4 2022
Q1 2023
Q2 2023
-0.38
-0.31
-0.24
-0.17

Details

Expected EPS
-0.23
Actual EPS
-0.35
Surprise EPS
-0.12
Surprise Percent
+52.17%

Description

Heron Therapeutics (HRTX) has reported earnings of -0.35 per share for Q2 2023.

0 Comments

Share your thoughts